ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (DNMRQ)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Kura Oncology, Inc. Common Stock, par value $0.0001 per share
Symbol: DNMRQ
Shares outstanding: 86,834,734 shares
Disclosed Ownership: 6,200,000 shares
Ownership: 7.1%
Form type: SCHEDULE 13G/A
Filing time: 15 Aug 2025, 12:26:59 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	7.1%	6,200,000	0	6,200,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	7.1%	6,200,000	0	6,200,000	/s/ Steven Boyd	Steven Boyd